Skip to main content

Advertisement

Articles

Page 3 of 95

  1. High background parenchymal uptake (BPU) on molecular breast imaging (MBI) has been identified as a breast cancer risk factor. We explored the feasibility of offering a short-term intervention of low-dose oral...

    Authors: Carrie B. Hruska, Katie N. Hunt, Amy Lynn Conners, Jennifer R. Geske, Kathleen R. Brandt, Amy C. Degnim, Celine M. Vachon, Michael K. O’Connor and Deborah J. Rhodes

    Citation: Breast Cancer Research 2019 21:38

    Content type: Research article

    Published on:

  2. Triple-negative breast cancers (TNBCs), which lack receptors for estrogen, progesterone, and amplification of epidermal growth factor receptor 2, are highly aggressive. Consequently, patients diagnosed with TN...

    Authors: Geraldine Vidhya Vijay, Na Zhao, Petra Den Hollander, Mike J. Toneff, Robiya Joseph, Mika Pietila, Joseph H. Taube, Tapasree R. Sarkar, Esmeralda Ramirez-Pena, Steven J. Werden, Maryam Shariati, Ruli Gao, Mary Sobieski, Clifford C. Stephan, Nathalie Sphyris, Noayuki Miura…

    Citation: Breast Cancer Research 2019 21:37

    Content type: Research article

    Published on:

  3. The seed and soil hypothesis was proposed over a century ago to describe why cancer cells (seeds) grow in certain organs (soil). Since then, the genetic properties that define the cancer cells have been heavil...

    Authors: Mohammad A. Alzubi, Tia H. Turner, Amy L. Olex, Sahib S. Sohal, Nicholas P. Tobin, Susana G. Recio, Jonas Bergh, Thomas Hatschek, Joel S. Parker, Carol A. Sartorius, Charles M. Perou, Mikhail G. Dozmorov and J. Chuck Harrell

    Citation: Breast Cancer Research 2019 21:36

    Content type: Research article

    Published on:

  4. Breast cancer is the second most common cause of cancer-related death among women. Advances in our understanding of the disease have translated into better diagnostics and more effective therapeutics, leading ...

    Authors: Laura Garcia-Estevez and Gema Moreno-Bueno

    Citation: Breast Cancer Research 2019 21:35

    Content type: Review

    Published on:

  5. Use of cyclin D1 (CCND1) gene amplification as a breast cancer biomarker has been hampered by conflicting assessments of the relationship between cyclin D1 protein levels and patient survival. Here, we aimed to c...

    Authors: Arian Lundberg, Linda S. Lindström, Jingmei Li, J. Chuck Harrell, Eva Darai-Ramqvist, Emmanouil G. Sifakis, Theodoros Foukakis, Charles M. Perou, Kamila Czene, Jonas Bergh and Nicholas P. Tobin

    Citation: Breast Cancer Research 2019 21:34

    Content type: Research article

    Published on:

  6. Mammographic density (MD) is an established risk factor for breast cancer. There are significant ethnic differences in MD measures which are consistent with those for corresponding breast cancer risk. This is ...

    Authors: Kirsty McLean, Ellie Darcey, Gemma Cadby, Helen Lund, Leanne Pilkington, Andrew Redfern, Sandra Thompson, Christobel Saunders, Elizabeth Wylie and Jennifer Stone

    Citation: Breast Cancer Research 2019 21:33

    Content type: Research article

    Published on:

  7. We characterized patterns of occurrence and the impact of neratinib-associated diarrhea in the absence of protocol-directed antidiarrheal prophylaxis or a formal diarrhea management plan using data from Extend...

    Authors: Joanne Mortimer, Jack Di Palma, Kendra Schmid, Yining Ye and Mohammad Jahanzeb

    Citation: Breast Cancer Research 2019 21:32

    Content type: Research article

    Published on:

  8. In a cancer-free environment in the adult, the skeleton continuously undergoes remodeling. Bone-resorbing osteoclasts excavate erosion cavities, and bone-depositing osteoblasts synthesize osteoid matrix that f...

    Authors: Alexus D. Kolb, Alison B. Shupp, Dimpi Mukhopadhyay, Frank C. Marini and Karen M. Bussard

    Citation: Breast Cancer Research 2019 21:31

    Content type: Research article

    Published on:

  9. The androgen receptor (AR) is an emerging prognostic marker and therapeutic target in breast cancer. AR is expressed in 60–80% of breast cancers, with higher prevalence among estrogen receptor-positive (ER+) t...

    Authors: Kevin H. Kensler, Meredith M. Regan, Yujing J. Heng, Gabrielle M. Baker, Michael E. Pyle, Stuart J. Schnitt, Aditi Hazra, Roswitha Kammler, Beat Thürlimann, Marco Colleoni, Giuseppe Viale, Myles Brown and Rulla M. Tamimi

    Citation: Breast Cancer Research 2019 21:30

    Content type: Research article

    Published on:

  10. Triple-negative breast cancer (TNBC) is an aggressive subset of breast carcinomas that lack expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2)...

    Authors: Wei Cao, Jieqing Li, Qiongyu Hao, Jaydutt V Vadgama and Yong Wu

    Citation: Breast Cancer Research 2019 21:29

    Content type: Review

    Published on:

  11. Inflammatory breast cancer (IBC) is a rare and rapidly progressive form of invasive breast cancer. The aim of this study was to explore the clinical evolution, stromal tumour-infiltrating lymphocytes (sTIL) in...

    Authors: C. Van Berckelaer, C. Rypens, P. van Dam, L. Pouillon, M. Parizel, K. A. Schats, M. Kockx, W. A. A. Tjalma, P. Vermeulen, S. van Laere, F. Bertucci, C. Colpaert and L. Dirix

    Citation: Breast Cancer Research 2019 21:28

    Content type: Research article

    Published on:

  12. TNF-related apoptosis-inducing ligand (TRAIL) receptor agonists are attractive anti-tumor agents because of their capability to induce apoptosis in cancer cells by activating death receptors (DR) 4 and 5 with ...

    Authors: Yoshimi Endo Greer, Samuel F. Gilbert, Brunilde Gril, Rajesh Narwal, Danielle L. Peacock Brooks, David A. Tice, Patricia S. Steeg and Stanley Lipkowitz

    Citation: Breast Cancer Research 2019 21:27

    Content type: Research article

    Published on:

  13. After the publication of this work [1] errors were noticed in Figs. 1a, 6a, and 8a—in which the β-actin bands were mistakenly presented.

    Authors: Manabu Emi, Ryungsa Kim, Kazuaki Tanabe, Yoko Uchida and Tetsuya Toge

    Citation: Breast Cancer Research 2019 21:26

    Content type: Correction

    Published on:

    The original article was published in Breast Cancer Research 2005 7:R940

  14. Although parity and age at first pregnancy are among the most known extrinsic factors that modulate breast cancer risk, their impact on the biology of subsequent breast cancer has never been explored in depth....

    Authors: Bastien Nguyen, David Venet, Matteo Lambertini, Christine Desmedt, Roberto Salgado, Hugo Mark Horlings, Françoise Rothé and Christos Sotiriou

    Citation: Breast Cancer Research 2019 21:25

    Content type: Research article

    Published on:

  15. Breast density is strongly related to breast cancer. Identifying associations between environmental exposures and density may elucidate relationships with breast cancer. Metals and polycyclic aromatic hydrocar...

    Authors: Alexandra J. White, Clarice R. Weinberg, Ellen S. O’Meara, Dale P. Sandler and Brian L. Sprague

    Citation: Breast Cancer Research 2019 21:24

    Content type: Research article

    Published on:

  16. Metastasis is the major cause of death from breast cancer. Colonization and adaption of metastatic cells in distant organs is a rate-limiting step of the cancer spreading. The underlying mechanisms responsible...

    Authors: Ya-Ling Hsu, Meng-Chi Yen, Wei-An Chang, Pei-Hsun Tsai, Yi-Chung Pan, Ssu-Hui Liao and Po-Lin Kuo

    Citation: Breast Cancer Research 2019 21:23

    Content type: Research article

    Published on:

  17. Breast cancer is the most common invasive cancer among women worldwide. Next-generation sequencing (NGS) has revolutionized the study of cancer across research labs around the globe; however, genomic testing i...

    Authors: Nicholas G. Smith, Rekha Gyanchandani, Osama S. Shah, Grzegorz T. Gurda, Peter C. Lucas, Ryan J. Hartmaier, Adam M. Brufsky, Shannon Puhalla, Amir Bahreini, Karthik Kota, Abigail I. Wald, Yuri E. Nikiforov, Marina N. Nikiforova, Steffi Oesterreich and Adrian V. Lee

    Citation: Breast Cancer Research 2019 21:22

    Content type: Research article

    Published on:

  18. Breast cancer patients under neoadjuvant chemotherapy includes a heterogeneous group of patients who eventually develop distal disease, not detectable by current methods. We propose the use of exosomal miRNAs ...

    Authors: Alba Rodríguez-Martínez, Diego de Miguel-Pérez, Francisco Gabriel Ortega, José Luis García-Puche, Inmaculada Robles-Fernández, José Exposito, Jordi Martorell-Marugan, Pedro Carmona-Sáez, María del Carmen Garrido-Navas, Christian Rolfo, Hugh Ilyine, José Antonio Lorente, Marta Legueren and María José Serrano

    Citation: Breast Cancer Research 2019 21:21

    Content type: Research article

    Published on:

  19. Non-coding RNAs and especially microRNAs have been discovered to act as master regulators of cancer initiation and progression. The aim of our study was to discover and characterize the function of yet functio...

    Authors: Daniela Schwarzenbacher, Christiane Klec, Barbara Pasculli, Stefanie Cerk, Beate Rinner, Michael Karbiener, Cristina Ivan, Raffaela Barbano, Hui Ling, Annika Wulf-Goldenberg, Stefanie Stanzer, Gabriel Rinnerthaler, Herbert Stoeger, Thomas Bauernhofer, Johannes Haybaeck, Gerald Hoefler…

    Citation: Breast Cancer Research 2019 21:20

    Content type: Research article

    Published on:

  20. Patients with early breast cancer (EBC) achieving pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT) have a favorable prognosis. Breast surgery might be avoided in patients in whom the pr...

    Authors: Simon Peter Gampenrieder, Andreas Peer, Christian Weismann, Matthias Meissnitzer, Gabriel Rinnerthaler, Johanna Webhofer, Theresa Westphal, Marina Riedmann, Thomas Meissnitzer, Heike Egger, Frederike Klaassen Federspiel, Roland Reitsamer, Cornelia Hauser-Kronberger, Katharina Stering, Klaus Hergan, Brigitte Mlineritsch…

    Citation: Breast Cancer Research 2019 21:19

    Content type: Research article

    Published on:

  21. Triple-negative breast cancer (TNBC) represents a heterogeneous group of ER- and HER2-negative tumors with poor clinical outcome. We recently reported that Pten-loss cooperates with low expression of microRNA-...

    Authors: Dong-Yu Wang, Deena M. A. Gendoo, Yaacov Ben-David, James R. Woodgett and Eldad Zacksenhaus

    Citation: Breast Cancer Research 2019 21:18

    Content type: Research article

    Published on:

  22. Cancer is frequently associated with tumor-related anemia, and many chemotherapeutic agents impair hematopoiesis, leading to impaired quality of life for affected patients. The use of erythropoiesis-stimulatin...

    Authors: Kruttika Bhat, Kiri Sandler, Sara Duhachek-Muggy, Claudia Alli, Fei Cheng, Neda A. Moatamed, Clara E. Magyar, Lin Du, Gang Li, Susan McCloskey, Erina Vlashi and Frank Pajonk

    Citation: Breast Cancer Research 2019 21:17

    Content type: Research article

    Published on:

  23. Epidemiologic evidence suggests that certain dietary patterns were associated with breast cancer risk, but the results have been inconclusive. We assessed the associations between different dietary patterns an...

    Authors: Yunjun Xiao, Junjie Xia, Liping Li, Yuebin Ke, Jinquan Cheng, Yaojie Xie, Winnie Chu, Polly Cheung, Jean Hee Kim, Graham A. Colditz, Rulla M. Tamimi and Xuefen Su

    Citation: Breast Cancer Research 2019 21:16

    Content type: Research article

    Published on:

  24. BRCA1-mutated cancers exhibit deficient homologous recombination (HR) DNA repair, resulting in extensive copy number alterations and genome instability. HR deficiency can also arise in tumors without a BRCA1 muta...

    Authors: Youdinghuan Chen, Yue Wang, Lucas A. Salas, Todd W. Miller, Kenneth Mark, Jonathan D. Marotti, Arminja N. Kettenbach, Chao Cheng and Brock C. Christensen

    Citation: Breast Cancer Research 2019 21:14

    Content type: Research article

    Published on:

  25. The adult mammary epithelium is composed of basal and luminal cells. The luminal lineage comprises two major cell populations, positive and negative for estrogen and progesterone receptors (ER and PR, respecti...

    Authors: Aurélie Chiche, Amandine Di-Cicco, Laura Sesma-Sanz, Laura Bresson, Pierre de la Grange, Marina A. Glukhova, Marisa M. Faraldo and Marie-Ange Deugnier

    Citation: Breast Cancer Research 2019 21:13

    Content type: Research article

    Published on:

  26. Limited understanding of the cancer biology of metastatic sites is a major factor contributing to poor outcomes in cancer patients. The regional lymph nodes are the most common site of metastasis in most solid...

    Authors: Abdi Ghaffari, Victoria Hoskin, Gulisa Turashvili, Sonal Varma, Jeff Mewburn, Graeme Mullins, Peter A. Greer, Friedemann Kiefer, Andrew G. Day, Yolanda Madarnas, Sandip SenGupta and Bruce E. Elliott

    Citation: Breast Cancer Research 2019 21:12

    Content type: Research article

    Published on:

  27. Elevated aerobic glycolysis rate is a biochemical alteration associated with malignant transformation and cancer progression. This metabolic shift unavoidably generates methylglyoxal (MG), a potent inducer of ...

    Authors: Marie-Julie Nokin, Justine Bellier, Florence Durieux, Olivier Peulen, Gilles Rademaker, Maude Gabriel, Christine Monseur, Benoit Charloteaux, Lieven Verbeke, Steven van Laere, Patrick Roncarati, Michael Herfs, Charles Lambert, Jean Scheijen, Casper Schalkwijk, Alain Colige…

    Citation: Breast Cancer Research 2019 21:11

    Content type: Research article

    Published on:

  28. Tumour hypoxia is a driver of breast cancer progression associated with worse prognosis and more aggressive disease. The cellular response to hypoxia is mediated by the hypoxia-inducible transcription factors ...

    Authors: Edward J. Jarman, Carol Ward, Arran K. Turnbull, Carlos Martinez-Perez, James Meehan, Chrysi Xintaropoulou, Andrew H. Sims and Simon P. Langdon

    Citation: Breast Cancer Research 2019 21:10

    Content type: Research article

    Published on:

  29. Immunochemotherapy, the combined use of immunotherapy and chemotherapy, has demonstrated great promise in several cancers. LTX-315 is an oncolytic peptide with potent immunomodulatory properties designed for t...

    Authors: Ketil A. Camilio, Meng-Yu Wang, Brynjar Mauseth, Stein Waagene, Gunnar Kvalheim, Øystein Rekdal, Baldur Sveinbjørnsson and Gunhild M. Mælandsmo

    Citation: Breast Cancer Research 2019 21:9

    Content type: Research article

    Published on:

  30. High mammographic density is associated with breast cancer and with delayed detection. We have examined whether localized density, at the site of the subsequent cancer, is independently associated with being d...

    Authors: Fredrik Strand, Edward Azavedo, Roxanna Hellgren, Keith Humphreys, Mikael Eriksson, John Shepherd, Per Hall and Kamila Czene

    Citation: Breast Cancer Research 2019 21:8

    Content type: Research article

    Published on:

  31. Clinical studies suggest that obesity, in addition to promoting breast cancer aggressiveness, is associated with a decrease in chemotherapy efficacy, although the mechanisms involved remain elusive. As chemoth...

    Authors: Camille Lehuédé, Xia Li, Stéphanie Dauvillier, Charlotte Vaysse, Camille Franchet, Emily Clement, David Esteve, Mélanie Longué, Léonor Chaltiel, Sophie Le Gonidec, Ikrame Lazar, Aline Geneste, Charles Dumontet, Philippe Valet, Laurence Nieto, Frédérique Fallone…

    Citation: Breast Cancer Research 2019 21:7

    Content type: Research article

    Published on:

  32. Epithelial-mesenchymal transition (EMT) occurs in the tumor microenvironment and presents an important mechanism of tumor cell intravasation, stemness acquisition, and metastasis. During metastasis, tumor cell...

    Authors: Hye Yeon Choi, Gwang-Mo Yang, Ahmed Abdal Dayem, Subbroto Kumar Saha, Kyeongseok Kim, Youngbum Yoo, Kwonho Hong, Jin-Hoi Kim, Cassian Yee, Kyung-Mi Lee and Ssang-Goo Cho

    Citation: Breast Cancer Research 2019 21:6

    Content type: Research article

    Published on:

  33. Many human breast cancers overexpress the E3 ubiquitin ligase MDM2 and its homolog MDMX. Expression of MDM2 and MDMX occurs in estrogen receptor α-positive (ERα+) breast cancer and triple-negative breast cancer (...

    Authors: Chong Gao, Gu Xiao, Alessandra Piersigilli, Jiangtao Gou, Olorunseun Ogunwobi and Jill Bargonetti

    Citation: Breast Cancer Research 2019 21:5

    Content type: Research article

    Published on:

  34. Dissemination of breast cancers to the brain is associated with poor patient outcome and limited therapeutic options. In this study we sought to identify novel regulators of brain metastasis by profiling mouse...

    Authors: Magdalena Kijewska, Carmen Viski, Frances Turrell, Amanda Fitzpatrick, Antoinette van Weverwijk, Qiong Gao, Marjan Iravani and Clare M. Isacke

    Citation: Breast Cancer Research 2019 21:4

    Content type: Research article

    Published on:

  35. Breast cancer is a partially heritable trait and genome-wide association studies (GWAS) have identified over 180 common genetic variants associated with breast cancer. We have previously performed breast cance...

    Authors: Joshua Hoffman, Laura Fejerman, Donglei Hu, Scott Huntsman, Min Li, Esther M. John, Gabriela Torres-Mejia, Larry Kushi, Yuan Chun Ding, Jeffrey Weitzel, Susan L. Neuhausen, Paul Lott, Magdalena Echeverry, Luis Carvajal-Carmona, Esteban Burchard, Celeste Eng…

    Citation: Breast Cancer Research 2019 21:3

    Content type: Research article

    Published on:

  36. The risk of recurrence for endocrine-treated breast cancer patients persists for many years or even decades following surgery and apparently successful adjuvant therapy. This period of dormancy and acquired re...

    Authors: Cigdem Selli, Arran K. Turnbull, Dominic A. Pearce, Ang Li, Anu Fernando, Jimi Wills, Lorna Renshaw, Jeremy S. Thomas, J. Michael Dixon and Andrew H. Sims

    Citation: Breast Cancer Research 2019 21:2

    Content type: Research article

    Published on:

  37. To obtain a deep understanding of the mechanism by which breast cancer develops, the genes involved in tumorigenesis should be analyzed in vivo. Mouse mammary gland can regenerate completely from a mammary ste...

    Authors: Hiroaki Tagaya, Kosuke Ishikawa, Yoshito Hosokawa, Shun Kobayashi, Yukino Ueoka, Mayuna Shimada, Yasuko Ohashi, Hirofumi Mikami, Mizuki Yamamoto, Tatsuya Ihara, Kentaro Kumazawa, Kosuke Sugihara, Naoki Goshima, Shinya Watanabe and Kentaro Semba

    Citation: Breast Cancer Research 2019 21:1

    Content type: Research article

    Published on:

  38. Fully automated assessment of mammographic density (MD), a biomarker of breast cancer risk, is being increasingly performed in screening settings. However, data on body mass index (BMI), a confounder of the MD...

    Authors: Sue Hudson, Kirsti Vik Hjerkind, Sarah Vinnicombe, Steve Allen, Cassia Trewin, Giske Ursin, Isabel dos-Santos-Silva and Bianca L. De Stavola

    Citation: Breast Cancer Research 2018 20:156

    Content type: Research article

    Published on:

  39. There is a growing interest in delivering more personalised, risk-based breast cancer screening protocols. This requires population-level validation of practical models that can stratify women into breast canc...

    Authors: Carolyn Nickson, Pietro Procopio, Louiza S. Velentzis, Sarah Carr, Lisa Devereux, Gregory Bruce Mann, Paul James, Grant Lee, Cameron Wellard and Ian Campbell

    Citation: Breast Cancer Research 2018 20:155

    Content type: Research article

    Published on:

  40. The role of tumor-associated macrophages (TAMs) in the cancer immune landscape and their potential as treatment targets or modulators of response to treatment are gaining increasing interest. TAMs display high...

    Authors: Vasiliki Pelekanou, Franz Villarroel-Espindola, Kurt A. Schalper, Lajos Pusztai and David L. Rimm

    Citation: Breast Cancer Research 2018 20:154

    Content type: Research article

    Published on:

    The Letter to this article has been published in Breast Cancer Research 2019 21:49

  41. Overdiagnosis, defined as the detection of a cancer that would not become clinically apparent in a woman’s lifetime without screening, has become a growing concern. Similar underlying risk of breast cancer in ...

    Authors: Wendy Yi-Ying Wu, Sven Törnberg, Klara Miriam Elfström, Xijia Liu, Lennarth Nyström and Håkan Jonsson

    Citation: Breast Cancer Research 2018 20:153

    Content type: Research article

    Published on:

  42. Case–control studies show that mammographic density is a better risk factor when defined at higher than conventional pixel-brightness thresholds. We asked if this applied to interval and/or screen-detected can...

    Authors: Tuong L. Nguyen, Ye K. Aung, Shuai Li, Nhut Ho Trinh, Christopher F. Evans, Laura Baglietto, Kavitha Krishnan, Gillian S. Dite, Jennifer Stone, Dallas R. English, Yun-Mi Song, Joohon Sung, Mark A. Jenkins, Melissa C. Southey, Graham G. Giles and John L. Hopper

    Citation: Breast Cancer Research 2018 20:152

    Content type: Research article

    Published on:

  43. The ability of solid tumor cells to resist anoikis, apoptosis triggered by cell detachment from the extracellular matrix (ECM), is thought to be critical for 3D tumor growth. ErbB2/Her2 oncoprotein is often ov...

    Authors: Iman Aftab Khan, Byong Hoon Yoo, Michael McPhee, Olivier Masson, Alexi Surette, Kelly Dakin-Hache, Tallal Younis, Gillian Bethune and Kirill V. Rosen

    Citation: Breast Cancer Research 2018 20:151

    Content type: Research article

    Published on:

  44. Prevention of triple-negative breast cancer (TNBC) is hampered by lack of knowledge about the drivers of tumorigenesis.

    Authors: Anjana Bhardwaj, Harpreet Singh, Celestine Marie Trinidad, Constance T. Albarracin, Kelly K. Hunt and Isabelle Bedrosian

    Citation: Breast Cancer Research 2018 20:150

    Content type: Research article

    Published on:

  45. Tamoxifen treatment greatly reduces a woman’s risk of developing a second primary breast cancer. There is, however, substantial variability in treatment response, some of which may be attributed to germline ge...

    Authors: Jennifer D. Brooks, Elizabeth A. Comen, Anne S. Reiner, Irene Orlow, Siok F. Leong, Xiaolin Liang, Lene Mellemkjær, Julia A. Knight, Charles F. Lynch, Esther M. John, Leslie Bernstein, Meghan Woods, David R. Doody, Kathleen E. Malone and Jonine L. Bernstein

    Citation: Breast Cancer Research 2018 20:149

    Content type: Research article

    Published on:

  46. The early detection of metastasis based on biomarkers in plasma may improve cancer prognosis and guide treatment. The aim of this work was to characterize alterations in metabolites of the arginine pathway, en...

    Authors: Kamil Kus, Agnieszka Kij, Agnieszka Zakrzewska, Agnieszka Jasztal, Marta Stojak, Maria Walczak and Stefan Chlopicki

    Citation: Breast Cancer Research 2018 20:148

    Content type: Research article

    Published on:

  47. Few published breast cancer (BC) risk prediction models consider the heterogeneity of predictor variables between estrogen-receptor positive (ER+) and negative (ER-) tumors. Using data from two large cohorts, ...

    Authors: Kuanrong Li, Garnet Anderson, Vivian Viallon, Patrick Arveux, Marina Kvaskoff, Agnès Fournier, Vittorio Krogh, Rosario Tumino, Maria-Jose Sánchez, Eva Ardanaz, María-Dolores Chirlaque, Antonio Agudo, David C. Muller, Todd Smith, Ioanna Tzoulaki, Timothy J. Key…

    Citation: Breast Cancer Research 2018 20:147

    Content type: Research article

    Published on:

  48. The pathophysiology of chemotherapy-induced peripheral neuropathy (CIPN) is not well understood. Currently, dose reduction is the only recommendation for alleviating symptoms, often leading to premature treatm...

    Authors: Jennifer M. Mongiovi, Gary R. Zirpoli, Rikki Cannioto, Lara E. Sucheston-Campbell, Dawn L. Hershman, Joseph M. Unger, Halle C. F. Moore, James A. Stewart, Claudine Isaacs, Timothy J. Hobday, Muhammad Salim, Gabriel N. Hortobagyi, Julie R. Gralow, G. Thomas Budd, Kathy S. Albain, Christine B. Ambrosone…

    Citation: Breast Cancer Research 2018 20:146

    Content type: Research article

    Published on:

  49. A combination of entinostat, all-trans retinoic acid, and doxorubicin (EAD) induces cell death and differentiation and causes significant regression of xenografts of triple-negative breast cancer (TNBC).

    Authors: Vanessa F. Merino, Soonweng Cho, Nguyen Nguyen, Helen Sadik, Athira Narayan, Conover Talbot Jr, Leslie Cope, Xian C. Zhou, Zhe Zhang, Balázs Győrffy and Saraswati Sukumar

    Citation: Breast Cancer Research 2018 20:145

    Content type: Research article

    Published on:

Annual Journal Metrics

Advertisement